Trastuzumab Deruxtecan

Trastuzumab deruxtecan is an antibody used to treat certain types of unresectable or metastatic HER2 positive breast cancer. Reference standards of Trastuzumab Deruxtecan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Trastuzumab Deruxtecan
    [catalogue_number] => PA PEP 001217
    [category_ids] => ,114,78,170,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 1826843-81-5
    [pslug] => 1826843-81-5-trastuzumab-deruxtecan-papep001217
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA PEP 001217

Trastuzumab Deruxtecan


  • Catalogue No.:PA PEP 001217

  • CAS :

    1826843-81-5

  • Molecular Formula : NA

  • Molecular Weight : NA

CPHI INDIA- 28, 30 November